Your browser doesn't support javascript.
loading
Lymphocyte infiltration predicts survival in chemotherapy-naive, triple-negative breast cancer and identifies patients with intrinsically good prognosis: have we been bringing owls to Athens?
Dubsky, P; Montagna, G; Ritter, M.
Affiliation
  • Dubsky P; Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Breast Center, Hirslanden Klinik St Anna, Lucerne. Electronic address: peter.dubsky@hirslanden.ch.
  • Montagna G; Breast Center, University Hospital of Basel, Basel, Switzerland; Department of Surgery, Memorial Sloan Kettering Cancer Center, Breast Service, New York, USA.
  • Ritter M; Breast Center, University Hospital of Basel, Basel, Switzerland.
Ann Oncol ; 30(12): 1849-1850, 2019 12 01.
Article in En | MEDLINE | ID: mdl-31626275
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Strigiformes / Triple Negative Breast Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Strigiformes / Triple Negative Breast Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Document type: Article